Visit Dohmen
We're pleased to announce that BioSoteria is now a member of the Dohmen Family of Companies.
Read More
|
Available Courses
Course 1: Drug and Device Development Regulation 2010 Will Solimene Award for Excellence in Medical Communication from the American Medical Writers Association (AMWA) Course 1 is appropriate for professionals entering or already in the pharmaceutical, biotechnology, and medical device industry in the areas of nonclinical research, clinical research, drug safety and pharmacovigilance, project management, regulatory affairs, medical information or medical affairs, quality assurance/compliance. Course 1 is also appropriate for professionals in academic centers, healthcare practice settings, or in government organizations who are involved in drug, biologic, or medical device development.
Course 2: Clinical Safety Surveillance With interactive content and engaging, real-world case study exercises, this course covers what you need to know from a clinical trial sponsor perspective regarding the requirements and practice of safety data collection, assessment, and reporting of serious adverse events (SAEs) reports during clinical development. The course will help you understand the FDA and EU regulations and related ICH guidance documents pertaining to safety surveillance activities of an investigational product, or marketed product being investigated for a new indication, different formulation or new dose, as it moves through the various stages of clinical studies until licensed for marketing.
Course 3: Postmarketing Pharmacovigilance With interactive content and engaging, real-world case study exercises, Course 3 delivers key information on the receipt, evaluation, and reporting of postmarketing spontaneous adverse drug reactions (ADRs), including the procedures that marketing authorization holders/license holders must follow to fulfill US and EU regulations. Similarities and differences between postmarketing pharmacovigilance (PV) regulations in the US and EU are covered.
THIS COURSE HAS BEEN APPROVED BY THE CALIFORNIA BOARD OF REGISTERED NURSING, PROVIDER #15586 FOR CONTINUING EDUCATION CREDITS. California Registered Nurses must retain this certificate for four years. Pharmacists may use courses approved by the California Board of Registered Nursing, towards their California continuing education requirement. (Section 1732.2(b) of the California Code of Regulations.) |